Case-control studies suggest that increased erythrocyte sodium-lithium countertransport may predict increased susceptibility to the development of essential hypertension. To characterize interindividual variation in sodium-lithium countertransport and its relation to blood pressure levels in the general population, we studied 1,475 Caucasians between 5 and 89 years of age (711 males and 764 females) ascertained through 266 households with children in the schools of Rochester, Minnesota. Individuals who were taking antihypertensive agents or combinations of estrogen and progesterone were not included hi the sample. A third-order polynomial regression on age accounted for only a small fraction of variability hi sodium-lithium countertransport (2.8% hi males, p<0.001; 2.1% in females, p<0.01), whereas a fourth-order regression on age accounted for a large proportion of variability in systolic blood pressure (45.7% hi males, /»<0.001; 52.5% in females, p<0.001) and diastoUc blood pressure (39.8% hi males, p<0.001; 33.0% hi females, /7<0.001). Mean sodium-lithium countertransport was higher in males than females at all ages; but the rank order of male and female means for systolic and diastoUc blood pressure was age dependent. Positively skewed distributions for age-, height-, and weight-adjusted sodium-lithium countertransport hi male and female cohorts between 5-19.9, 20-49.9, and 50-89.9 years of age were explained significantly better by postulating a mixture of two partially overlapping sodiumlithium countertransport distributions rather than a single normal distribution (p<0.01). Among men hi the 20-49.9-year-old cohort, adjusted sodium-lithium countertransport values hi the upper distribution were associated with higher systolic and diastoUc blood pressure (mean±SD) than values hi the lower distribution (for systolic blood pressure: 115±11 vs. 111±11 mm Hg, /?<0.07; for diastoUc blood pressure: 71.2±8.0 vs. 68.4±8.6 mm Hg, /K0.08). Among females in the 50-89.9-year-old cohort, adjusted sodium-Uthium countertransport values hi the upper distribution were associated with significantly greater diastolic blood pressure than values in the lower distribution (77± 10 vs. 70±9 nun Hg, p<0.03). We conclude that 1) changes hi systolic and diastoUc blood pressure levels with age and gender are not accompanied by similar changes hi sodiumUthium countertransport; 2) two different sodium-lithium countertransport distributions are evident at aU ages and hi both sexes, as expected if a factor responsible for increased sodium-Uthium countertransport were a presymptomatic predictor of essential hypertension; and 3) among individuals not receiving antihypertensive drugs, increased sodium-Uthium countertransport makes only a smaU contribution to the prediction of higher blood pressure hi specific age and sex subgroups from the general population. {Hypertension 1989;13:378-391) A mong alterations in sodium ion transport in patients with essential hypertension, an increase in erythrocyte (RBC) sodium-
of Caucasian patients with essential hypertension have found significantly higher mean levels of NaLi countertransport in comparison with normotensive control subjects. 3 -6 Many young normotensive offspring of patients with essential hypertension also have elevated Na-Li countertransport 3   -7   -8 ; however, increased levels are usually not found in patients with secondary forms of hypertension. Although the magnitude of average difference and the degree of overlap in Na-Li countertransport values between normotensive and essential hypertensive samples has varied among studies, the consistency with which elevated levels are found in patients with essential hypertension and their normotensive offspring has suggested that the Na-Li countertransport phenotype may serve as a predictor of elevated blood pressure or susceptibility to the development of essential hypertension. 71112 In contrast to the well characterized differences in Na-Li countertransport between normotensive and hypertensive samples, there have been no studies of Na-Li countertransport variability or its relation to blood pressure levels in the general population. 13 Because hypertensive individuals are frequently treated with blood pressure-lowering drugs, study of the relation between blood pressure and Na-Li countertransport throughout the entire range of blood pressure levels has not been possible. Nevertheless, considerable interindividual variation in Na-Li countertransport has been observed among individuals without diagnosed and treated hypertension. 214 In samples of unrelated adult blood donors and members of nuclear families, 215 mixtures of two different Na-Li countertransport distributions were characterized by large differences in the mean values for the two distributions. Moreover, in some samples of normotensive and borderline hypertensive subjects not receiving antihypertensive drugs, positive correlations of Na-Li countertransport with systolic or diastolic blood pressure have been reported. 2 -5 - 6 These observations suggest that variations in Na-Li countertransport may be associated with blood pressure differences even among individuals whose blood pressure levels are within the normotensive range. However, inferences from these previous studies are limited by the small size of the samples considered, their nonrandom selection, the limited age ranges of subjects studied, or the failure of analyses to control for covariates such as age, body size, and gender that affect both blood pressure and Na-Li countertransport. 2,4.5,9,16-18 The present study was undertaken to characterize Na-Li countertransport variability and its relation to blood pressure levels among Caucasians from the general population who were not receiving medications known to alter either of these traits. Our specific objectives were 1) to compare the pattern of change in expected mean Na-Li countertransport level with age and gender to the pattern for systolic and diastolic blood pressure; 2) to estimate the relative contributions of age and body size to the gender-specific variation in Na-Li countertransport and blood pressure; 3) to assess whether the frequency distribution of Na-Li countertransport is explained by a mixture of two normal distributions in both sexes after controlling for variation in age and body size; and 4) to evaluate whether increased countertransport predicts higher blood pressure levels among individuals without diagnosed and treated hypertension. Our findings are consistent with the hypothesis that a factor responsible for increased Na-Li countertransport may be a presymptomatic marker for risk of essential hypertension but suggest that it does not predict large blood pressure differences among normotensive individuals in the general population.
Subjects and Methods

Sample
All aspects of this study involving human subjects were approved by the Institutional Review Board of the Mayo Clinic and Foundation. In January 1984, we arranged for officials of the Rochester, Minnesota, school system to send letters describing the purpose of the study to 5,270 households having two or more children enrolled in the city's public and parochial schools. We requested that members of each household willing to consider participation in the study return an enclosed questionnaire providing the phone number, address, and names of individuals in the household. From a total of 1,812 questionnaires returned (response rate 34.4%), 159 households were judged unsuitable for sampling because they did not want to be contacted (n=105), they planned to move away from Rochester within the next year (n=12), they reported only adopted children in the household (n=17), or they gave various other reasons (n=25) that participation would be unlikely (e.g., unwillingness to visit the clinic or have blood drawn). Between December 1984, and March 1987, we contacted 436 of the 1,653 households eligible for sampling, and members from 300 households agreed to participate in the study (household participation rate=68.8%). By March 1, 1987, 1,991 family members had visited the clinic, and clinical and laboratory data from 1,713 individuals ascertained through 266 households had been entered into a computer database in a form accessible for statistical analyses.
Given our objective to evaluate the naturally occurring relation between blood pressure and Na-Li countertransport, we excluded from this study 198 individuals taking one or more antihypertensive drugs (95 males, 103 females). Since oral contraceptive agents have been reported to increase both Na-Li countertransport 19 and blood pressure 20 levels, we also excluded 40 additional women taking estrogen in combination with progesterone. Together, these exclusions resulted in the sample of 1,475 individuals presented in Results. No pregnant women or indi-viduals receiving hemodialysis treatment for chronic renal failure were included in this sample. All but six subjects (i.e., 99.6% of the sample) stated their race to be Caucasian; the 0.4 percent of the sample that was not Caucasian included one American Indian (a female age 33 years), two children of mixed American Indian and Caucasian descent (a male age 10 years and a female age 6 years), and three adopted Oriental children (one male age 16 and two females ages 8 and 16 years).
Because most hypertensive individuals living in Rochester, Minnesota, and the surrounding communities are detected and receive antihypertensive drug therapy, 21 -22 the prevalence of definite hypertension in this sample (i.e., systolic blood pressureS:160 mm Hg or diastolic blood pressure s=95 mm Hg) was lower than reported for other samples from the general population that have also included treated hypertensive individuals in the definition of this condition. 2324 Among individuals less than50 years of age included in this sample (see Table 2 ), the prevalence of definite hypertension was less than 1%. Among adults 50 years of age and older, only 14% had systolic blood pressure 160 mm Hg or greater (13% of males and 14.7% of females), and only 2.5% had diastolic blood pressure 95 mm Hg or greater (5% of males and 0.7% of females). These considerations suggest that inferences from this study may be generalizable only to individuals whose naturally occurring blood pressure levels are below the range of definite hypertension.
Study Protocol
All study participants visited the Mayo Clinic between 7:00 and 9:00 AM for blood drawing and examination. Subjects were asked to fast overnight before the clinic visit and to complete a questionnaire regarding use of prescription and nonprescription medications. At the beginning of the clinic visit, each subject gave his informed consent; afterwards, a blood sample was drawn by a trained phlebotomist. A physician then reviewed each subject's medical history and performed a brief physical examination. Subjects were required to remove their shoes and outdoor clothing. Height was measured with a wall stadiometer; weight was determined on a beam balance; and blood pressure was measured with a random zero sphygmomanometer (Hawksley & Sons, Ltd., West Sussex, England). A cuff size appropriate for the subject's arm was chosen according to recommendations of the American Heart Association. 23 Three blood pressure readings, at least 2 minutes apart, were measured in the right arm after the subject had been sitting quietly for at least 5 minutes. The pressure at Karotkoff phase I sound was taken as systolic blood pressure in all subjects. Diastolic blood pressure was determined at the occurrence of KarotkofT phase IV sound in children less than 13 years of age 26 and at Karotkoff phase V sound in all older subjects. Averages of the three systolic and three diastolic blood pressure readings taken on each subject were used in the analyses reported below.
Interobserver differences in systolic and diastolic blood pressure averages were assessed by having two physicians use a double-headed stethoscope to measure the blood pressure of 24 subjects on 24 occasions during the course of this study. There were no significant differences in blood pressure means measured by different examiners (p>0.95), and correlation between observers across subjects was greater than 0.94 for both systolic and diastolic blood pressure means (p<0.001). Hence, the expected contribution of multiple observers to interindividual variation in blood pressure in this study is small.
Determination of Maximal Rate of Sodium-Lithium Countertransport
Blood samples anticoagulated with heparin were kept at 4° C until processing for determination of RBC lithium efflux. Assays were performed on the day of blood collection in samples from 1,455 subjects; samples from 10 subjects were assayed after overnight preservation as described below. The maximal capacity for sodium-gradient dependent lithium efflux was determined using methods developed by Canessa and colleagues 327 with the minor modifications described by Smith et al. 28 The technique uses RBC loaded with lithium ions to estimate the maximal rate of Na-Li countertransport as the difference between rate of lithium efflux into a medium containing sodium ions minus rate of efflux into a medium in which external sodium has been replaced by magnesium ions. The loading procedure achieves intracellular lithium concentrations sufficient to saturate the internal lithium transport site and reduces the intracellular concentration of sodium to minimize its competition with lithium at the internal transport site. The intracellular lithium concentration achieved in RBC after the lithium loading procedure was measured in blood samples from 1,246 subjects in the present sample; the mean±SD was 7.76±0.87 mmol/1 RBC. Details of the procedures followed to determine RBC lithium efflux are fully described in our previous publications.
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Reproducibility of Sodium-Lithium Countertransport Assay
Before undertaking this study, we estimated the variability among replicate Na-Li countertransport assays on the same individual and compared this with the variability among individuals. Blood samples were obtained from eight healthy normotensive individuals (four males, four females) on four separate occasions over a period of 4 months (10/23/84-2/26/85). Because of the anticipated need in our population study occasionally to delay measurements of Na-Li countertransport until the day after blood collection, we also determined the effects of overnight storage of RBC on the Na-Li countertransport assay. We measured Na-Li countertransport both on the day of blood collection (fresh cells) and the next day after storing the RBC overnight at 4° C in a solution consisting of 140 mM KC1, 10 mM NaCl, 1 mM MgCl 2) 10 mM Tris MOPS, pH 7.4 at 4° C, and 5 mM glucose (preserved cells). Duplicate assays were performed in both fresh and preserved cells on each occasion. For the analysis of variance of these data, a mixed effects model 29 was used that considered the state of RBC on the day of the assay (i.e., fresh or preserved) as a fixed effect and variability between individuals, variability between samples from an individual on different days, and variability between replicate assays on the same day as random effects. The components of variance were assumed to be the same for fresh and preserved cells. We found that the difference between Na-Li countertransport means for fresh and preserved cells was not statistically significant (p>0.80). The components of variance accounted for the following percentages of total variability in these Na-Li countertransport data: interindividual variation, 86.0%; day-to-day variation, 11.5%; and variation between replicate assays on the same day, 2.5%. Thus, the major fraction of variation among observations in this sample was due to interindividual differences. The coefficient of variability for assays done with fresh cells on the same individual on different days was 8.9% and for replicate assays on the same day 7.5%. We also performed measurements of Na-Li countertransport in fresh RBC drawn from 17 laboratory workers on 2-11 separate occasions over the 28-month period that our population-based study was underway (12/84-3/87). Coefficients of variation calculated for each individual varied from 3.3% to 22.4% with an average (±SD) of 11.5±5.0%. These analyses suggest that a single measurement provides a reliable estimate of the Na-Li countertransport value in an individual.
Missing Data
Measurements of all variables of interest were not obtained in a small number of individuals in the sample. Height and weight were not measured in one adult and blood pressure was not measured in another. Systolic and diastolic blood pressure data for one child were excluded because all fourth and fifth phase diastolic blood pressure readings were recorded at zero. Technical problems resulted in failure to complete Na-Li countertransport measurements in 10 subjects.
Analysis of Data
A variety of standard statistical methods 29 were employed in carrying out the analyses presented in this study. The analysis of variance was used to contrast age-and sex-specific means, and Scheffe's simultaneous confidence intervals were constructed for each pairwise comparison of these means. Equality of variances among age-and sex-specific subgroups was tested using the F statistic suggested by Box. 30 Standard multiple regression methods were used to estimate the contributions of age, height, and weight variability to variation in systolic blood pressure, diastolic blood pressure, and Na-Li countertransport. The covariance analysis was used to evaluate the homogeneity of the regression among subgroups. Test statistics with associated p values less than 0.05 were considered statistically significant; p values appear in the text only when not given in an accompanying table.
We used a maximum likelihood method suggested by Day 31 to evaluate whether one, two, or three Guassian distributions provided the best explanation for the age-, height-, and weight-adjusted Na-Li countertransport values in each age-sex cohort comprising the present sample (see Figure 2 and Table 4 ). The maximum likelihood estimates for the parameters defining each model were obtained by the estimation maximization (EM) algorithm method 32 using the incrementation procedure suggested by Ott. 33 The difference between the maximum values of the log,, likelihood of a particular model and a competing model that restricts certain parameters to hypothesized values forms the basis for testing hypothesis. This difference multiplied by -2 is distributed approximately as &X 1 distribution with degrees of freedom equal to the number of parameters restricted by the hypothesis. The hypothesis of equal variances for the distributions in the two-and three-component models fit the data as well (p>0.10) as models allowing unequal variances in the separate component distributions. Only in two of the cohorts (i.e., females 20-49.9 and females 50-89.9 years of age) did models with three Na-Li countertransport distributions fit the data significantly better (p<0.05) than the two-component models. Thus, the preponderance of evidence, including results in four of the six cohorts in the present sample and findings from our previous studies of blood bank donors 2 and an independent sample of families, 15 indicates that models with three Na-Li countertransport distributions do not consistently provide better fit than models with two distributions. For these reasons, we present below only the comparison between the model with two Gaussian distributions having equal variances and the model with a single Guassian distribution.
Materials
Chemicals and biochemicals of the highest grade of purity were purchased from J.T. Baker Chemical Company (Phillipsburg, New Jersey) and Sigma Chemical Company (St. Louis, Missouri). All solutions were prepared in deionized, double-distilled water. Table 1 summarizes by decade and gender the descriptive statistics for age, height, and weight of the 1,475 individuals in this study. Overall, males comprised 48.2% of the sample and females comprised 51.8% of the sample; only in the third and seventh decades did the proportion of males deviate significantly from the estimate for the remainder of the sample. Ages ranged from 5.2-89.3 years for males and from 5.4-86.3 years for females. Mean age (±SD) for all males was significantly less than for females (33.1 ±21.2 vs. 36.1 ±21.9 years); however, at each decade the difference in mean age between males and females was not statistically significant, and the rank order of mean ages for males and females was not constant across all decades. Mean height and mean weight in the second through ninth decades were significantly greater in males than females. In both genders, mean height and weight rose to their greatest values in the third and fourth decades and declined slightly in subsequent decades.
Results
Description of the Sample
Descriptive statistics for blood pressure are given by decade and gender in Table 2 . In both sexes, systolic blood pressure increased progressively with age in this sample. Between the first and ninth decades, mean systolic blood pressure rose by 52.3 mm Hg in males (p<0.01) and by 66.9 mm Hg in females (/?<0.001). Males in the second, third, and fourth decades had significantly higher mean systolic blood pressure than females; however, females in the sixth, seventh, and ninth decades had significantly higher mean systolic blood pressure than males. At maximum, the mean systolic blood pressure in males exceeded that in females by 9.4 mm Hg in the third decade (p<0.01), and mean systolic blood pressure in females exceeded that in males by 13.7 mm Hg in the ninth decade (p<0.05). The variance of systolic blood pressure increased significantly with age in both genders, and was significantly greater in females than males in the first, fourth, and seventh decades.
Mean diastolic blood pressure also rose with increasing age after the second decade ( Table 2) . The highest mean level was reached in the sixth decade in males and in the ninth decade in females. In males, between the second and sixth decades, mean diastolic blood pressure increased by 20.6 mm Hg (p<0.01); in females, between the second and ninth decades, it increased by 16.6 mm Hg (p<0.01). Mean diastolic blood pressure was higher in males than females in the third through the eighth decades, with a maximal difference between the sexes of 5.6 mm Hg (/><0.01) in the third decade. Significant differences in the variance of diastolic blood pressure were present among the decade groups for each gender and between males and females in the second decade.
In contrast to the large and progressive increases in blood pressure with age, mean Na-Li countertransport levels rose only slightly and then declined with increasing age in the sample ( Table 2) . The highest mean level of Na-Li countertransport (±SD) was reached in the third decade in males (335 ±100 /xmol/1 RBC/hr) and in the sixth decade in females (287±102 /imol/1 RBC/hr). However, with the subsequent declines by the seventh decade, mean NaLi countertransport was no different in males or females than in the first decade. Mean Na-Li countertransport was higher in males than in females at each decade; the magnitude of these differences reached statistical significance in the second through the sixth decades. The variance of Na-Li countertransport differed significantly among decades for each gender and between the gender groups in the second, fourth, and fifth decades.
Variability in Blood Pressure and Sodium-Lithium Countertransport Attributable to Concomitant Variables
The predicted regressions of blood pressure and Na-Li countertransport on age for each gender are Figure 1 . The progressive increases in blood pressure with age were best characterized by fourth-order polynomial regressions that accounted for a large fraction of the total variability in systolic blood pressure (45.7% in males, p<0.00\; 52.5% in females, /?<0.001) and diastolic blood pressure (39.8% in males, p<0.001; 33.0% in females, p<0.001). In contrast, the modest rise and subsequent decline in Na-Li countertransport with age in this sample was characterized by a third-order polynomial regression that explained only a small fraction of the total variability in this trait in either gender (2.8% in males, p<0.001; 2.1% in females, p<0.01). As expected from the contrasts between genders of mean blood pressure and Na-Li countertransport presented in Table 2 , the regression on age for each of these variables differed significantly between males and females (p<0.001). The regression slopes, as well as the overall regression relations, were significantly different between the genders for each variable (p<0.05). In general, the predicted levels of all three traits rose more rapidly and reached higher levels in males than females between childhood and early adulthood. For diastolic blood pressure and Na-Li countertransport, the proportion of variability attributable to age was greater among males than among females; but for systolic blood pressure, the proportion of variability attributable to age was greater among females than among males.
Differences in level and trend of blood pressure and Na-Li countertransport with age and gender suggested that factors contributing to variability in these traits might be age and sex specific. Consequently, the males and females were divided into subgroups from 5 to 19.9, 20 to 49.9, and 50 to 89.9 years of age to provide six separate age-sex cohorts for further study. The ages 20 and 50 years used to partition the male and female groups corresponded approximately to points of inflection in the rise of systolic blood pressure with age ( Figure 1 ) and defined age intervals associated with different phases in the relations of blood pressure and Na-Li countertransport to age. Within each age-sex cohort, we then estimated the combined contributions of age and two measures of body size (i.e., height and weight) to explain interindividual variability in blood pressure and Na-Li countertransport. For each trait, the proportion of variability attributable to the concomitants differed considerably among the age and sex cohorts ( Table 3 ). The slopes of the regression relations of diastolic blood pressure and Na-Li countertransport on the concomitants differed significantly among the age cohorts for one or both of the gender groups. In addition, the regression slopes of systolic blood pressure on the concomitants differed significantly between males and females in the 5-19.9 and 20-49.9-year-old cohorts. Of note, the proportion of variability in Na-Li countertransport attributable to the concomitants was not different in males and females but increased progressively from by guest on September 23, 2017 http://hyper.ahajournals.org/ 5.0% in males and 6.6% in females ages 5-19.9, to 15.4% in males and 12.6% in females ages 50-89.9. In contrast, the concomitants made their largest contributions to systolic blood pressure variability in the 5-19.9-year-old cohort (42% in males, 28.2% in females) and to diastolic blood pressure in the 20-49.9-yearold cohort (20.0% in males, 17.2% in females).
Residual Sodium-Lithium Countertransport Variability Distribution of adjusted sodium-lithium countertransport values.
After adjusting Na-Li countertransport values to remove variability attributable to the age, height, and weight differences within each age-sex cohort, frequency distribution histograms were constructed (Figure 2 ). The distribution of adjusted Na-Li countertransport values was positively skewed toward higher values in each of the cohorts. Consequently, we considered the possibility that a commingling of two Gaussian distributions might explain the distribution of adjusted Na-Li countertransport values better than a single distribution. Based on the differences in likelihoods of the two competing models, we rejected with a high degree of confidence the hypothesis of a single distribution in favor of the alternative hypothesis of two partially overlapping Gaussian distributions in each of the six cohorts (Table 4 ). Probability density functions determined by estimates of the two means, a single standard deviation, and the proportion of individuals in each hypothesized distribution are shown superimposed on the frequency histograms in Figure 2 . Displacement between the means of the two hypothesized distributions varied among the cohorts from two to four times the estimated standard deviation about each mean. Separation of the two means was greatest for the 20-49.9-yearold cohort (2.83 SD units in males; 3.97 SD units in females) and least for the 5-19.9-year-old cohort (2.07 SD units in males; 2.46 SD units in females). The predicted proportion of individuals belonging to the second Na-Li countertransport distribution with a higher mean value varied from 1.9% in 20-49.9-year-old females to 19.1% in 20-49.9-year-old males. Note in Table 4 that before fitting the models with two distributions, the residual variance in Na-Li countertransport was significantly heterogeneous among the age and sex cohorts (p<0.001); afterwards, the estimated standard deviation about the two hypothesized means was quite similar in all cohorts (-70 ^mol/1 RBC/hr) except the 5-19.9-year-old females (Table 4) .
Relation of blood pressure to sodium-lithium countertransport variability. We assessed whether blood pressure differences were associated with interindividual variation in Na-Li countertransport by comparing age-, height-, and weight-adjusted blood pressure levels between individuals from the two different Na-Li countertransport distributions (Table  5) . For this analysis individuals in each age-sex cohort were assigned probabilities of belonging to each of the two hypothesized distributions based on their adjusted Na-Li countertransport values. An individual was considered to belong to one of the Na-Li countertransport distributions (and not to the other) when his adjusted Na-Li countertransport value had a probability greater than 0.8 of falling within that distribution and less than 0.2 of falling within the other distribution. Individuals whose adjusted Na-Li countertransport values were within the range of overlap between the distributions and did not meet these criteria were not considered in this analysis. Among males and females less than 20 years of age, we found no evidence of blood pressure differences between individuals identified as belonging to the two different Na-Li countertransport distributions. In the 20-49.9-year-old cohorts, there was evidence of higher systolic and diastolic blood pressure (mean±SD) among males belonging to the upper Na-Li countertransport distribution compared with those belonging to the lower distribution (systolic blood pressure, 115±11 vs. 111±11 mm Hg, p<0.07; diastolic blood pressure, 71.8±8 vs. 68±9 mm Hg, p<0.08), although the magnitude of these differences only reached borderline statistical significance. However, among females 50 years of age and older, mean diastolic blood pressure was significantly higher for those with Na-Li countertransport values in the upper distribution compared with those with values in the lower distribution (77±10 vs. 70±9 mm Hg, p<0.03).
Discussion
The present study characterizes interindividual variability in Na-Li countertransport and its relation to blood pressure among Caucasians not medicated with agents known to influence either of these traits. To our knowledge, this is the first comprehensive assessment of Na-Li countertransport variability and its contribution to the prediction of blood pressure levels in a large sample that included children and adults from the general population. The pattern and magnitude of variation in systolic and diastolic blood pressure with age and gender in this sample (Table 2, Figure 1 ) resembled that described for randomly sampled children and adults in acculturated societies. 2434 - 36 Also as noted in previous population-based samples, 2434 -35 the agespecific variability in systolic blood pressure increased with age in both sexes ( Table 2 ). The typical characteristics of blood pressure variation with age and gender in this sample suggests that it accurately reflects features of blood pressure variability found in the general population, even though individuals on antihypertensive medications or combinations of estrogen and progesterone were excluded. We can expect that estimates from this study regarding the relation of Na-Li countertransport to blood pressure and other concomitant variables are generally representative of similar Caucasian groups living in modern societies.
The pattern and magnitude of variation in Na-Li countertransport levels between the age and gender groups in this sample differed from that for systolic or diastolic blood pressure (Table 2, Figure 1) . In contrast to the large and progressive rises in systolic and diastolic blood pressure with increasing age, mean and predicted Na-Li countertransport levels increased only slightly between childhood and adulthood. Total interindividual variation in each trait, judged by its coefficient of variability among all subjects of either sex, was greater for Na-Li countertransport (28.2% in males; 28.1% in females) than for systolic blood pressure (14.9% in males; 18.9% in females) or for diastolic blood pressure (21.9% in males; 18.6% in females); yet, differences in age accounted for less than 3% of the variation in Na-Li countertransport but more than 45% of the variation in systolic and more than 30% of the variation in diastolic blood pressure. More- The sodium-lithium (Na-Li) countertransport values in the table were adjusted for first-and second-order effects of age, height, and weight variation within each age-sex cohort. Units for the Na-Li countertransport means and standard deviations are micromoles per liter erythrocytes per hour. One female in the 5-19.99 and one in the 50-89.99 year old cohort with adjusted Na-Li countertransport values of 609 and 754, respectively, were omitted from the analysis.
*The estimated standard deviation within each distribution. tFor each model f, and f 2 are the relative frequencies of the first and second distributions, respectively. tx 2 statistic (2 df) for the maximum likelihood test of "goodness of fit" to two versus one Gaussian distribution. \p value for significance of the x 2 statistic.
over, the mean level of Na-Li countertransport was higher in males than females at all ages, while the rank order of male and female means for systolic and diastolic blood pressure was age dependent (Table 2) . This nonparallelism between blood pressure and Na-Li countertransport suggests that factors contributing to blood pressure variation with age and gender do not exert similar influences on Na-Li countertransport. Clearly, the large differences in blood pressure among the age and sex subgroups in this sample could not be attributed to corresponding variation in Na-Li countertransport. Hence, we conclude that Na-Li countertransport is not a predictor of age-and gender-related variation in blood pressure in the general population. This sample revealed considerable heterogeneity among different age and sex cohorts in the relation of Na-Li countertransport to concomitant variables. The regression of Na-Li countertransport on age was gender specific and nonlinear (third-order) over the age range sampled. Accordingly, the direction and magnitude of variation in Na-Li countertransport with age depended on both the age interval and the gender of subjects considered, in contrast to suppositions that are based on samples not drawn from the general population. 9 Although the present sample confirms earlier reports that males have higher mean Na-Li countertransport than females, 2 -413 it also indicates that the magnitude of this difference varies with age. The margin by which both mean and predicted Na-Li countertransport level in males exceeded that in females was largest in the third and ninth decades and smallest in the first and seventh decades ( Table 2 and Figure 1) . Finally, the proportion of Na-Li countertransport variability attributable to age and body size increased progressively with age in both sexes, reaching a maximum in late adulthood (Table 3) ; in contrast, age and body size made their largest contributions to systolic and diastolic blood pressure variability in childhood or early adulthood. These features of heterogeneity in the relation of Na-Li countertransport to gender, age, and body size, as well as differences between Na-Li couiitertransport and blood pressure in their relations to the same concomitants, were not evaluated in previous samples. Raw systolic and diastolic blood pressures were adjusted for first-and second-order effects of age, height, and weight variation with each age-sex cohort. Units for the means and standard deviations of systolic and diastolic blood pressure (BP) are mm Hg. The n for each distribution indicates the number of individuals having sodium-lithium (Na-Li) countertransport values associated with a probability greater than 0.80 of belonging to that distribution.
*/? value for contrast of blood pressure means between individuals from the two Na-Li countertransport distributions.
bility should be considered in the design and interpretation of future studies, particularly if Na-Li countertransport levels are to be contrasted between normotensive and hypertensive cohorts with different gender, age, or body size distribution.
Although variation in age and body size accounted for up to 15% of gender-specific variability in Na-Li countertransport (Table 3) , considerable unexplained variability remained after adjustment to remove the effects of these covariates. Within each age-sex cohort, the distribution of adjusted Na-Li countertransport values could be explained significantly better by postulating a mixture of two normal distributions with equal variances rather than a single normal distribution ( Figure 2 and Table 4 ). Accordingly, residual variation in Na-Li countertransport was partitioned into two components: one due to displacement between the means of the two hypothesized distributions, and the other due to dispersion about each of the mean. In each cohort, the difference in mean Na-Li countertransport levels between the two hypothesized distributions exceeded two within-group standard deviation units. These analyses extend previous studies of the dis-tribution of Na-Li countertransport values 215 by establishing evidence for two Na-Li countertransport distributions among individuals from the general population after controlling for the effects of gender, age, and body size differences.
It is unlikely that exclusion of individuals taking antihypertensive medications or combinations of estrogen and progesterone influenced the conclusion regarding two Na-Li countertransport distributions, since most of the excluded persons had essential hypertension or were using oral contraceptives and their Na-Li countertransport levels were elevated (data not shown). Inclusion of these individuals would increase the estimated proportion of the population belonging to the upper Na-Li countertransport distribution and consequently strengthen evidence for two distributions. Given the reports of significantly higher mean Na-Li countertransport among patients with essential hypertension compared with selected normotensive control subjects'-918 and the accumulating evidence from the present study and previous studies of randomly ascertained normotensive individuals, 213 we can confidently infer that the Caucasian population, in general, is composed of at least two subgroups of individuals characterized by a large difference in their mean Na-Li countertransport values.
Evidence of two Na-Li countertransport distributions in the general population suggests that a factor exerting a large effect on this trait may be expressed in a fraction of individuals. 37 In view of family and twin studies indicating that more than 50% of interindividual variation in Na-Li countertransport is attributable to genetic influence, 1538 -40 it is reasonable to ask whether segregation of alleles at a single gene locus can account for the mixture of Na-Li countertransport distributions. Complex segregation analysis of Na-Li countertransport levels among members of 10 large pedigrees, initially led Dadone and colleagues 38 to conclude that a model of polygenic inheritance, which postulates many genes each with only a small effect on Na-Li countertransport, best explains phenotypic variance in this trait. However, transmission models that do not incorporate an additional major factor having a large effect on Na-Li countertransport levels are inconsistent with the evidence for two distributions of this trait in the general population. In a subsequent analysis incorporating additional data from a total of 1,989 persons in 89 pedigrees, Hasstedt and colleagues 40 found that segregation of alleles at a single gene locus accounted for a mixture of two Na-Li countertransport distributions only in a subset of 17 pedigrees prone to early coronary heart disease. Since the pedigrees studied by these investigators were selected because of an unusually high or premature incidence of cardiovascular diseases, their results may not be representative of the general population. In a preliminary study of 50 nuclear families ascertained without regard to health status, we found evidence favoring a major gene model with polygenes to account for transmission of Na-Li countertransport levels between generations, although a major environmental effect plus polygenes could not be totally excluded in some of the families. 15 Future analyses of the data from members of the families in the present study will more accurately estimate the contribution that genetic factors make to Na-Li countertransport variation and establish the extent to which a major gene effect is responsible for the mixture of distributions that characterizes this trait in the general population.
It is remarkable that the magnitude of difference between the means for the two hypothesized Na-Li countertransport distributions in this and previous studies of randomly ascertained normotensive subjects 215 is very similar to that estimated between patients ascertained because of personal or family history of essential hypertension and selected normotensive control subjects. 2 Because of this similarity and the positive linear correlations found between Na-Li countertransport and blood pressure among some normotensive and borderline hypertensive subjects, 2 -5 -6 a major objective of this study was to assess the relation of blood pressure to Na-Li countertransport levels among individuals who were not treated with drugs known to affect either of these traits. Specifically, we evaluated whether the putative factor responsible for displacement between the two Na-Li countertransport distributions, possibly the segregation of alleles at a single gene locus, might be associated with increased blood pressure. Higher blood pressure among individuals identified with the upper Na-Li countertransport distribution was present in two of the four adult cohorts but not among children or youths less than 20 years of age (Table 5 ). Only among 50-89.9-year-old females did the increment in mean diastolic blood pressure (+A=7 mm Hg) reach statistical significance. Thus, in this sample without persons on antihypertensive medications or combinations of estrogen and progesterone, the hypothesized factor responsible for displacement between the two NaLi countertransport distributions predicted only small blood pressure differences among subjects in specific age and sex cohorts.
An important caveat in interpreting these results is that individuals with naturally occurring blood pressure levels at the upper extreme of the blood pressure range were underrepresented in our sample. This limitation cannot be easily overcome in communities such as Rochester, Minnesota, where most hypertensive persons are detected and treated with blood pressure-lowering drugs. 21 - 23 Were it possible to include a representative number of individuals with untreated essential hypertension, a stronger association between increased Na-Li countertransport and elevated blood pressure might be established. However, among children and youths less than 20 years of age, it is doubtful that exclusion of individuals on antihypertensive medications affects the conclusion that increased Na-Li counter-transport does not predict higher blood pressure, since the prevalence of hypertension is extremely low in this segment of the population. 24 -4142 Moreover, if estimates are correct that less than 50% of individuals with essential hypertension have elevated Na-Li countertransport, 118 addition of untreated individuals with essential hypertension may have only a modest impact on the relation between blood pressure and Na-Li countertransport among adults. Thus, it is reasonable to suggest that the overall contribution of Na-Li countertransport variation to prediction of blood pressure levels in the general population is probably small, particularly when judged by comparison with the large effects that age, body size, and gender have on blood pressure ( Figure 2 , Table 3 ).
If increased Na-Li countertransport is not a strong and consistent predictor of elevated blood pressure level per se, is it possible that it may still predict the occurrence of essential hypertension? Some argue it can not, 43 since many individuals who develop essential hypertension, and some of their offspring who are at increased risk of essential hypertension, do not have high Na-Li countertransport levels. 4445 However, insistence on a one-to-one correspondence between increased Na-Li countertransport and elevated blood pressure or essential hypertension ignores the likelihood that these conditions have multifactorial etiologies. If a factor influencing Na-Li countertransport levels contributes to the pathogenesis of essential hypertension, we do not anticipate its presence in every person with essential hypertension, nor do we expect every person with the factor to develop elevated blood pressure. The present findings are entirely consistent with the hypothesis that a factor responsible for a large increase in Na-Li countertransport may be a marker of increased susceptibility to essential hypertension. The presence of two Na-Li countertransport distributions among children and youths indicates that the factor is expressed early in life before the development of elevated blood pressure, as expected of a presymptomatic indicator of disease susceptibility. Since many other factors influence blood pressure, it is not surprising that this, or any other, single factor can account for only a small fraction of blood pressure variation. Carefully designed cohort studies will be necessary to quantitate the excess risk of essential hypertension attributable to increased Na-Li countertransport.
Despite long-standing recognition that heredity plays an imporant role in the etiology of essential hypertension, the search for biochemical traits relating genetic variability to interindividual differences in blood pressure has yielded few candidates. 46 Evidence suggests that Na-Li countertransport may be one such intervening phenotype that may serve as a probe into the genetic basis of interindividual differences in blood pressure or the occurrence of essential hypertension. The present study advances our understanding of this putative indicator of susceptibility to essential hypertension by characterizing its variation in the general population and its relation to age-and sex-specific blood pressure levels. If allelic variation at a single gene locus accounts for large difference in the distribution of the Na-Li countertransport phenotype in the general population, additional information regarding an individual's probable genotype at such a locus may enhance the ability to predict risk of essential hypertension.
